Risk of Disease Relapse After Discontinuing Anti-TNF Therapy in Patients With Perianal Fistulizing Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Crohn's & Colitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
J Crohns Colitis 2024 Jan 27;18(1)134-143, S Ten Bokkel Huinink, D Thomassen, EW Steyerberg, RWM Pauwels, MJ Casanova, G Bouguen, JWY Mak, T Molnár, AJ Lobo, JB Seidelin, A Amiot, G D'Haens, P Rivière, L Guidi, R Bor, WC Lin, L Peyrin-Biroulet, JP Gisbert, C Janneke van der Woude, AC de VriesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.